Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Thomas Budd

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|June 22, 2016
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancerShruti R Tiwari, Prasun Mishra, Paola Raska, et al.
The Journal of Molecular Diagnostics : JMD|January 12, 2013
Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinomaZhen Wang, Bryce P Portier, Aaron M Gruver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
American Journal of Clinical Oncology|March 14, 2023
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary MetastasesWafa Asha, Sami Koro, Zachary Mayo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancerG Thomas Budd, Massimo Cristofanilli, Mathew J Ellis, et al.
The New England Journal of Medicine|August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancerMassimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|February 16, 2026
Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathyCarla Bou Dargham, Ken B Johnson, Alper Sen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A statusRaymond Tubbs, William E Barlow, G Thomas Budd, et al.
JACC. Cardiovascular Imaging|August 11, 2018
Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic AbnormalitiesSrikanth Koneru, Kimi Sato, Adam Goldberg, et al.
Journal of the American Academy of Dermatology|July 17, 2019
Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based studyRosalynn R Z Conic, Giovanni Damiani, Alice Frigerio, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|June 22, 2016
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancerShruti R Tiwari, Prasun Mishra, Paola Raska, et al.
The Journal of Molecular Diagnostics : JMD|January 12, 2013
Automated quantitative RNA in situ hybridization for resolution of equivocal and heterogeneous ERBB2 (HER2) status in invasive breast carcinomaZhen Wang, Bryce P Portier, Aaron M Gruver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survivalDaniel F Hayes, Massimo Cristofanilli, G Thomas Budd, et al.
American Journal of Clinical Oncology|March 14, 2023
Stereotactic Body Radiation Therapy for Sarcoma Pulmonary MetastasesWafa Asha, Sami Koro, Zachary Mayo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancerG Thomas Budd, Massimo Cristofanilli, Mathew J Ellis, et al.
The New England Journal of Medicine|August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancerMassimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|February 16, 2026
Time-course based assessment of patient factors and their relationship to chemotherapy induced peripheral neuropathyCarla Bou Dargham, Ken B Johnson, Alper Sen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A statusRaymond Tubbs, William E Barlow, G Thomas Budd, et al.
JACC. Cardiovascular Imaging|August 11, 2018
Pertuzumab/Trastuzumab Breast Cancer Therapy Is Associated With Complex Hemodynamic AbnormalitiesSrikanth Koneru, Kimi Sato, Adam Goldberg, et al.
Journal of the American Academy of Dermatology|July 17, 2019
Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based studyRosalynn R Z Conic, Giovanni Damiani, Alice Frigerio, et al.
Pageof 11